Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (5.947.925 €): DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY Hor01.01.2020 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Text
DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY
Atrial fibrillation (AF) is an increasingly common arrhythmia in the aging European population. Its prevalence will more than double by the year 2050 affecting 5% of EU women and men aged ≥65 years. AF carries a high risk of stroke, heart failure, and dementia, which result in a significant loss of quality-adjusted life years and high mortality. The EU guiding principles for active aging (no. 17468/12) recommend disease prevention to maximise healthy life, and early detection of AF is recommended by the European Society of Cardiology (ESC). Nonetheless, to date, a risked-based screening strategy is lacking. AFFECT-EU’s major goal is the development of a risk-based, accurate, and ready for implementation AF screening algorithm, using digital devices, for early AF detection in the community. For this objective we will (1) Develop a risk-based AF screening algorithm, by combining the available information from the largest outcome trials (Danish LOOP, STROKESTOP, SAFER) and multiple screening studies across Europe (Ntotal>100,000) including health modifiers and biomarkers; (2) Refine the stratification of high-risk populations in a personalised approach through exploration of distinct digital screening methods and multiple health determinants in deeply-phenotyped population cohorts; (3) Validate the AFFECT-EU risked-based screening recommendations in a meta-analysis of European and world-wide studies; (4) Demonstrate cost benefits and acceptability of AF screening across different European healthcare systems; (5) Identify the AF screening potential to be taken up by differing healthcare systems; (6) Foster the dissemination of results and adoption of the risked-based AF screening algorithm in the ESC (an AFFECT-EU partner) guidelines. AFFECT-EU will develop the first targeted, risk-based AF screening algorithm, and thus contribute to the reduction of AF-related health inequities, morbidity and mortality in Europe.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| 90.000 € | |
| Edinburgh Napier University | 157.438 € |
| 103.375 € | |
| 92.500 € | |
| Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca | 91.283 € |
| 126.919 € | |
| KOMPETENZNETZ VORHOFFLIMMERN e. V. | 109.498 € |
| Karolinska Institutet | 0,00 € |
| 821.039 € | |
| Mcmaster University | 58.763 € |
| PFIZER PHARMA GmbH | 0,00 € |
| ROCHE DIAGNOSTICS INTERNATIONAL AG | 0,00 € |
| Region Hovedstaden | 846.991 € |
| 459.945 € | |
| 673.854 € | |
| THE Trustees OF Boston University | 25.500 € |
| THE University OF Sydney | 0,00 € |
| The Chancellor Masters and Scholars of the University of Cambridge | 229.870 € |
| The Chancellor, Masters and Scholars of the University of Oxford | 249.564 € |
| The University of Birmingham | 35.785 € |
| UNIVERSITAETSKLINIKUM AACHEN | 89.320 € |
| UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF | 1.471.735 € |
| UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK | 17.252,00 € |
| Umea Universitet | 53.250 € |
| Universita Degli Studi DI Modena E Reggio Emilia | 89.046 € |
| Universitetet I Tromsoe - Norges Arktiske Universitet | 55.000 € |
Quelle: https://cordis.europa.eu/project/id/847770
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
Die Visualisierungen zu "Academisch Medisch Centrum BIJ DE Universiteit Van Amsterdam - EU-Förderung (5.947.925 €): DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
